Inhibikase Therapeutics News

Inhibikase Therapeutics | 424B3: Prospectus

Jun 27 12:58 ET

Inhibikase Therapeutics | EFFECT: Others

Jun 27 06:03 ET

Inhibikase Therapeutics | 424B5: Prospectus

May 22 08:59 ET

Inhibikase Therapeutics | 424B5: Prospectus

May 20 07:10 ET

Inhibikase Therapeutics | 424B5: Prospectus

Feb 1 16:54 ET

Inhibikase Therapeutics | EFFECT: Others

Apr 5, 2023 00:15 ET

Inhibikase Therapeutics | 424B3: Prospectus

Apr 4, 2023 16:57 ET

Inhibikase Therapeutics | 424B3: Prospectus

Feb 8, 2023 09:13 ET

Inhibikase Therapeutics | EFFECT: Others

Feb 8, 2023 00:15 ET

Inhibikase Therapeutics | 424B5: Prospectus

Jan 27, 2023 08:25 ET

Inhibikase Therapeutics | 424B5: Prospectus

May 16, 2022 21:47 ET

Inhibikase Therapeutics | EFFECT: Others

Feb 14, 2022 00:15 ET

Inhibikase Therapeutics | 424B4: Prospectus

Jun 17, 2021 16:31 ET

Inhibikase Therapeutics | EFFECT: Others

Jun 16, 2021 00:15 ET

Inhibikase Therapeutics | 424B4: Prospectus

Dec 28, 2020 06:04 ET

Inhibikase Therapeutics | EFFECT: Others

Dec 23, 2020 00:15 ET

Inhibikase Therapeutics | 8-A12B: Registration of a class of securities on a national securities exchange

Oct 29, 2020 06:08 ET